[1] Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV.Osteogenesis in transplants of bone marrow cells.J EmbryolExpMorphol. 1966; 16(3):381-390. [2] Bianco P, Robey PG, Simmons PJ.Mesenchymal stem cells: revisiting history, concepts, and assays.Cell Stem Cell. 2008;2(4):313-319. [3] Bongso A, Fong CY.The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.Stem Cell Rev. 2013;9(2):226-240. [4] Zhang L, Tan X, Dong C,et al. In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells.Int J Dev Neurosci. 2012;30(6):471-477. [5] Peng J, Wang Y, Zhang L, et al. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Brain Res Bull. 2011;84(3):235-243. [6] Banas A.Purification of adipose tissue mesenchymal stem cells and differentiation toward hepatic-like cells.Methods Mol Biol. 2012;826: 61-72. [7] Shevde N.Stem Cells: Flexible friends.Nature. 2012;483(7387): S22-26. [8] Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.Lancet. 2008;371(9624):1579-1586. [9] Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.Cell Stem Cell. 2009;5(1):54-63. [10] Johnson K, Zhu S, Tremblay MS, et al. A stem cell-based approach to cartilage repair.Science. 2012;336(6082):717-721. [11] Liu R, Zhang Z, Lu Z, et al. Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination.Stem Cells Dev. 2013;22(7):1053-1062. [12] Lee HJ, Lee JK, Lee H, et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.Neurobiol Aging. 2012;33(3): 588-602. [13] Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.PLoS One. 2012;7(8):e43683. [14] 毛开云,范月蕾,王跃,等.间充质干细胞治疗产品开发现状与趋势[J].中国生物工程杂志,2017,37(10):126-135.[15] Ramanathan R, Rupert S, Selvaraj S, et al. Role of Human Wharton's Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d-Galactosamine Induced Acute Liver Injury in Mice.J ClinExpHepatol. 2017;7(3):205-214. [16] Thomas KE, Moon LD.Will stem cell therapies be safe and effective for treating spinal cord injuries.Br Med Bull. 2011;98:127-142. [17] Nadri S, Soleimani M.Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy. 2007;9(8):729-737. [18] In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.Stem Cells. 2004;22(7):1338-1345. [19] 穆晓红,徐林,赵子义,等.人胎盘与骨髓源性间充质干细胞体外培养及生物学特性对比[J].中国组织工程研究与临床康复, 2009,13(19): 3708-3712.[20] Secunda R, Vennila R, Mohanashankar AM, et al. Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.Cytotechnology. 2015;67(5):793-807. [21] Bojani? I, Golubi?Cepuli? B.Umbilical cord blood as a source of stem cells. Acta Med Croatica. 2006;60(3):215-225. [22] Li G, Zhang XA, Wang H, et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics. 2009;9(1):20-30. [23] Bieback K, Kern S, Kocaömer A, et al. Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood.Biomed Mater Eng. 2008;18 (1 Suppl): S71-76. [24] Kikuchi-Taura A, Taguchi A, Kanda T, et al. Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells.Cytotherapy. 2012;14(4):441-450. [25] Fong CY, Subramanian A, Biswas A, et al. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.J Cell Biochem. 2016;117(4):815-827. [26]Shivakumar SB, Bharti D, Subbarao RB, et al. DMSO and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.J Cell Biochem. 2016;117(10):2397-2412. [27] Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture.Nat Methods. 2011;8(5):424-429. [28] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy. 2006;8(4): 315-317. [29] Balci D, Can A.The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking.Curr Stem Cell Res Ther. 2013;8(1):60-72. [30] Capelli C, Pedrini O, Valgardsdottir R, et al. Clinical grade expansion of MSCs.Immunol Lett. 2015;168(2):222-227. [31] Priya N, Sarcar S, Majumdar AS, et al. Explant culture: a simple, reproducible, efficient and economic technique for isolation of mesenchymal stromal cells from human adipose tissue and lipoaspirate.J Tissue Eng Regen Med. 2014;8(9):706-716. [32] Chen PM, Yen ML, Liu KJ, et al. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.J Biomed Sci. 2011;18:49. [33] Horwitz EM, Dominici M.How do mesenchymal stromal cells exert their therapeutic benefit.Cytotherapy.2008;10(8):771-774. [34] Liu S, Yuan M, Hou K, et al. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.Cell Immunol. 2012;278(1-2):35-44. |